Abuse of Regulatory Procedures in the Pharmaceutical Sectorâ€â€Developments Since the General Court’s Judgment in AstraZeneca
NCAs do indeed appear to have been emboldened in their enforcement of Article 102 TFEU in the pharmaceutical sector. Kristina Nordlander & Patrick Harrison (Sidley Austin)